From : Ekaterine Adamia <eadamia@moh.gov.ge>
To : Tamar Gabunia <tgabunia@moh.gov.ge>
Subject : RE: Vosevi arrival delay-Urgent
Received On : 13.03.2019 09:04
Attachments :

თამუნა, იქნებ დავამატოთ რომ ავიაზედდებული (AWB) გამოგვიგზავნონ. ყოველთვის გვიგზავნიან წესით. ამით უფრო მარტივად ვიპოვით ტვირთს.

 

პატივისცემით,

 

ეკა

 

From: Ben Dunne [mailto:Ben.Dunne@gilead.com]
Sent: 13 March, 2019 12:53
To: Tamar Gabunia ; Graeme Robertson ; Aysan Murtezaoglu
Cc: Ekaterine Adamia ; Mariam Darakhvelidze ; a.gamkrelidze@ncdc.ge; David Sergeenko ; Sean Barr ; David Novoa ; AOEM_SCM ; GAP
Subject: RE: Vosevi arrival delay-Urgent

 

Dear Tamar,

 

Im very surprised to hear this. Im just waiting on the operators from our transport company to arrive into office in 1 hour and I will advise status.

Apologies for this, I will resolve quickly.  

 

Best Regards,

Ben

 

From: Tamar Gabunia [mailto:tgabunia@moh.gov.ge]
Sent: 13 March 2019 05:57
To: Graeme Robertson; Ben Dunne; Aysan Murtezaoglu
Cc: Ekaterine Adamia; Mariam Darakhvelidze; a.gamkrelidze@ncdc.ge; David Sergeenko; Sean Barr; David Novoa; AOEM_SCM; GAP
Subject: Vosevi arrival delay-Urgent

 

Dear Ben

 

I hope all is well with you. Based on shipment confirmation we expected Vosevi arrival yesterday on March 12th. For some reasons the shipment did not arrive. Would it be possible for you to track the parcel to find out the current status and anticipated delivery date?

Many thanks for your understanding and cooperation.

Sincerely

Tamar Gabunia

 

 

From: Tamar Gabunia
Sent: Friday, March 8, 2019 8:18 PM
To: Graeme Robertson <Graeme.Robertson@gilead.com>; Ben Dunne <Ben.Dunne@gilead.com>; Aysan Murtezaoglu <Aysan.Murtezaoglu@gilead.com>
Cc: Ekaterine Adamia <eadamia@moh.gov.ge>; Mariam Darakhvelidze <mdarakhvelidze@moh.gov.ge>; a.gamkrelidze@ncdc.ge; David Sergeenko <dsergeenko@moh.gov.ge>; Sean Barr <Sean.Barr@gilead.com>; David Novoa <David.Novoa@gilead.com>; AOEM_SCM <AOEM_SCM@gilead.com>; GAP <GAP@gilead.com>
Subject: Re: Vosevi Request Documents - shipping details and documents

 

Dear Graeme

Many thanks for your follow up. I will confirm the receipt and keep you posted on clinical status/progress.

With kind regards

Tamar

 

 

 

Sent from my Samsung Galaxy smartphone.

 

 

-------- Original message --------

From: Graeme Robertson <Graeme.Robertson@gilead.com>

Date: 3/8/19 8:15 PM (GMT+04:00)

To: Ben Dunne <Ben.Dunne@gilead.com>, Tamar Gabunia <tgabunia@moh.gov.ge>, Aysan Murtezaoglu <Aysan.Murtezaoglu@gilead.com>

Cc: Ekaterine Adamia <eadamia@moh.gov.ge>, Mariam Darakhvelidze <mdarakhvelidze@moh.gov.ge>, a.gamkrelidze@ncdc.ge, David Sergeenko <dsergeenko@moh.gov.ge>, Sean Barr <Sean.Barr@gilead.com>, David Novoa <David.Novoa@gilead.com>, AOEM_SCM <AOEM_SCM@gilead.com>, GAP <GAP@gilead.com>

Subject: RE: Vosevi Request Documents - shipping details and documents

 

Dear Ben,

 

Thank you so so much for your rapid response in this urgent case. I really appreciate.

 

Tamar,

Please do let us know when you have safely received the product and we wish the best outcome for the patient, please do let us know the outcome.

 

Best wishes

 

Graeme

 

Graeme.A Robertson

Executive Director,  Africa & CIS

Access Operations & Emerging Markets 

--------------------------------------------------------------------------------------------------------------------------------------------------

Gilead Sciences Europe Ltd • Registered as a limited company in England and Wales • Registered number 05510315

Registered office: South Building • 2 Roundwood Avenue • Stockley Park • Uxbridge • UB11 1AZ • England

Telephone: +44(0)208 587 2228 • Mobile: +44(0)7789 268 043 • Fax: +44(0)208 744 6773

 

From: Ben Dunne
Sent: 08 March 2019 11:26
To: Graeme Robertson; Tamar Gabunia; Aysan Murtezaoglu
Cc: Ekaterine Adamia; Mariam Darakhvelidze; a.gamkrelidze@ncdc.ge; David Sergeenko; Sean Barr; David Novoa; AOEM_SCM; GAP
Subject: Vosevi Request Documents - shipping details and documents

 

Dear Tamar,

 

Please find shipping documents attached and flight details below.

 

Flight      From                     To

LH2519/11   DUBLIN                   MUNICH

LH2558/12   MUNICH                   TBILISI, GEORGIA

 

From:                      DUBLIN

To:                        TBILISI, GEORGIA

Carrier:                   LH   = LUFTHANSA CARGO AG

 

Departure:                                          11 March 2019, 18:05  Hrs from DUBLIN

Estimated Time of Arrival:            12 March 2019, 17:15  Hrs at TBILISI, GEORGIA

 

If you need anything further, please do not hesitate to ask us.

 

Kindest Regards,

 

 

Ben Dunne

Supply Chain Specialist III

Gilead Sciences Ireland UC

Eagle House

Elm Road

Dublin Airport Logistics Park

St. Margaret’s

Co. Dublin

K67 W240

Ireland

Direct phone: +353 1 2913571

Fax number:  +353 1 2944031

e-mail: ben.dunne@gilead.com

cid:image001.png@01D2A874.E80DD8E0

 

 

 

From: Graeme Robertson
Sent: 07 March 2019 16:07
To: Tamar Gabunia; Aysan Murtezaoglu
Cc: Ekaterine Adamia; Mariam Darakhvelidze; a.gamkrelidze@ncdc.ge; David Sergeenko; Sean Barr; David Novoa; Ben Dunne
Subject: RE: Vosevi Request Documents

 

Dear Tamar,

 

We have managed to process all the documents and my colleague Ben is getting the flight details and will inform you of these shortly.

 

I really want to thank Ben for turning this around so quickly, Thank you and best wishes

 

Graeme

 

Graeme.A Robertson

Executive Director,  Africa & CIS

Access Operations & Emerging Markets 

--------------------------------------------------------------------------------------------------------------------------------------------------

Gilead Sciences Europe Ltd • Registered as a limited company in England and Wales • Registered number 05510315

Registered office: South Building • 2 Roundwood Avenue • Stockley Park • Uxbridge • UB11 1AZ • England

Telephone: +44(0)208 587 2228 • Mobile: +44(0)7789 268 043 • Fax: +44(0)208 744 6773

 

From: Tamar Gabunia [mailto:tgabunia@moh.gov.ge]
Sent: 07 March 2019 15:52
To: Graeme Robertson; Aysan Murtezaoglu
Cc: Ekaterine Adamia; Mariam Darakhvelidze; a.gamkrelidze@ncdc.ge; David Sergeenko
Subject: Re: Vosevi Request Documents

 

Thanks a lot! Much appriciated!

 

 

 

Sent from my Samsung Galaxy smartphone.

 

 

-------- Original message --------

From: Graeme Robertson <Graeme.Robertson@gilead.com>

Date: 3/7/19 7:27 PM (GMT+04:00)

To: Tamar Gabunia <tgabunia@moh.gov.ge>, Aysan Murtezaoglu <Aysan.Murtezaoglu@gilead.com>

Cc: Ekaterine Adamia <eadamia@moh.gov.ge>, Mariam Darakhvelidze <mdarakhvelidze@moh.gov.ge>, a.gamkrelidze@ncdc.ge, David Sergeenko <dsergeenko@moh.gov.ge>

Subject: RE: Vosevi Request Documents

 

Thank you Tamar

 

I will get these processed and the product shipped ASAP

Best wishes

 

GRAEME

 

Graeme.A Robertson

Executive Director,  Africa & CIS

Access Operations & Emerging Markets 

--------------------------------------------------------------------------------------------------------------------------------------------------

Gilead Sciences Europe Ltd • Registered as a limited company in England and Wales • Registered number 05510315

Registered office: South Building • 2 Roundwood Avenue • Stockley Park • Uxbridge • UB11 1AZ • England

Telephone: +44(0)208 587 2228 • Mobile: +44(0)7789 268 043 • Fax: +44(0)208 744 6773

 

From: Tamar Gabunia [mailto:tgabunia@moh.gov.ge]
Sent: 07 March 2019 15:16
To: Graeme Robertson; Aysan Murtezaoglu
Cc: Ekaterine Adamia; Mariam Darakhvelidze; a.gamkrelidze@ncdc.ge; David Sergeenko
Subject: Vosevi Request Documents

 

​Dear Graeme

With this I am sending the requested documents to support the ministry request on Vosevi for personal use by the patient indicated in the request letter. 

Please kindly let me know if anything else is required. I would appreciate if you could let us know an anticipated delivery date. 

Many thanks for all your assistance. 

Best

Tamar Gabunia 

 

 

 

 

DISCLAIMER If you have received this message in error, please contact the sender immediately by return e-mail and notify the sender and then delete this message (including any attachments) from your system. This communication and any attachments contain information which is confidential and may also be legally privileged. It is for the exclusive use of the intended recipient(s). If you are not the intended recipient(s) please note that any form of disclosure, distribution, copying or use of this communication or the information in it or in any attachments is strictly prohibited and may be unlawful. If your e-mail contains any personal information then we will process this according to our Privacy Statement located on Gilead.com. E-mail communications cannot be guaranteed to be secure or error free, as information could be intercepted, corrupted, amended, lost, destroyed, arrive late or incomplete, or contain viruses. Gilead does not accept liability for any such matters or their consequences. Anyone who communicates with Gilead by e-mail is taken to accept the risks in doing so. Gilead has taken every reasonable precaution to ensure that any attachment to this e-mail has been swept for viruses. However, Gilead cannot accept liability for any damage sustained as a result of viruses and would advise that you carry out your own virus checks before opening any attachment. Gilead Sciences Europe Ltd ; Registered as a limited company in England and Wales ; Registered number 5510315 Registered office: South Building ; 2 Roundwood Avenue ; Stockley Park ; Uxbridge ; UB11 1AF ; England

DISCLAIMER If you have received this message in error, please contact the sender immediately by return e-mail and notify the sender and then delete this message (including any attachments) from your system. This communication and any attachments contain information which is confidential and may also be legally privileged. It is for the exclusive use of the intended recipient(s). If you are not the intended recipient(s) please note that any form of disclosure, distribution, copying or use of this communication or the information in it or in any attachments is strictly prohibited and may be unlawful. If your e-mail contains any personal information then we will process this according to our Privacy Statement located on Gilead.com. E-mail communications cannot be guaranteed to be secure or error free, as information could be intercepted, corrupted, amended, lost, destroyed, arrive late or incomplete, or contain viruses. Gilead does not accept liability for any such matters or their consequences. Anyone who communicates with Gilead by e-mail is taken to accept the risks in doing so. Gilead has taken every reasonable precaution to ensure that any attachment to this e-mail has been swept for viruses. However, Gilead cannot accept liability for any damage sustained as a result of viruses and would advise that you carry out your own virus checks before opening any attachment. Gilead Sciences Europe Ltd ; Registered as a limited company in England and Wales ; Registered number 5510315 Registered office: South Building ; 2 Roundwood Avenue ; Stockley Park ; Uxbridge ; UB11 1AF ; England

DISCLAIMER If you have received this message in error, please contact the sender immediately by return e-mail and notify the sender and then delete this message (including any attachments) from your system. This communication and any attachments contain information which is confidential and may also be legally privileged. It is for the exclusive use of the intended recipient(s). If you are not the intended recipient(s) please note that any form of disclosure, distribution, copying or use of this communication or the information in it or in any attachments is strictly prohibited and may be unlawful. If your e-mail contains any personal information then we will process this according to our Privacy Statement located on Gilead.com. E-mail communications cannot be guaranteed to be secure or error free, as information could be intercepted, corrupted, amended, lost, destroyed, arrive late or incomplete, or contain viruses. Gilead does not accept liability for any such matters or their consequences. Anyone who communicates with Gilead by e-mail is taken to accept the risks in doing so. Gilead has taken every reasonable precaution to ensure that any attachment to this e-mail has been swept for viruses. However, Gilead cannot accept liability for any damage sustained as a result of viruses and would advise that you carry out your own virus checks before opening any attachment. Gilead Sciences Europe Ltd ; Registered as a limited company in England and Wales ; Registered number 5510315 Registered office: South Building ; 2 Roundwood Avenue ; Stockley Park ; Uxbridge ; UB11 1AF ; England